Cargando…

Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase Domain

Janus kinase 3 (JAK3) tyrosine kinase has a central role in the control of lymphopoiesis, and mutations in JAK3 can lead to either severe combined immunodeficiency or leukemia and lymphomas. JAK3 associates with the common gamma chain (γc) receptor and functions in a heteromeric signaling pair with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raivola, Juuli, Hammarén, Henrik M., Virtanen, Anniina T., Bulleeraz, Vilasha, Ward, Alister C., Silvennoinen, Olli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287396/ https://www.ncbi.nlm.nih.gov/pubmed/30560087 http://dx.doi.org/10.3389/fonc.2018.00560

Ejemplares similares

Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
por: Raivola, Juuli, et al.
Publicado: (2019)

Nucleotide-binding mechanisms in pseudokinases
por: Hammarén, Henrik M., et al.
Publicado: (2016)

Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
por: T. Virtanen, Anniina, et al.
Publicado: (2019)

Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain
por: Virtanen, Anniina T., et al.
Publicado: (2023)

Crystal structures of the Jak2 pseudokinase domain and the pathogenic mutant V617F
por: Bandaranayake, Rajintha M., et al.
Publicado: (2012)

In vivo impact of JAK3 A573V mutation revealed using zebrafish
por: Basheer, Faiza, et al.
Publicado: (2022)

Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021)

Structure of a pseudokinase domain switch that controls oncogenic activation of Jak kinases
por: Toms, Angela V., et al.
Publicado: (2013)

Leukemia-associated truncation of granulocyte colony-stimulating factor receptor impacts granulopoiesis throughout the life-course
por: Bulleeraz, Vilasha, et al.
Publicado: (2023)

JAK1 Pseudokinase V666G Mutant Dominantly Impairs JAK3 Phosphorylation and IL-2 Signaling
por: Grant, Alice H., et al.
Publicado: (2023)

Oncogenic Signalling of PEAK2 Pseudokinase in Colon Cancer
por: Lecointre, Céline, et al.
Publicado: (2022)

Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response
por: Palmroth, Maaria, et al.
Publicado: (2021)

PD-L1 expression is regulated by ATP-binding of the ERBB3 pseudokinase domain
por: Li, Yamu, et al.
Publicado: (2022)

Oncogenic Ras mutant causes the hyperactivation of NF‐κB via acceleration of its transcriptional activation
por: Tago, Kenji, et al.
Publicado: (2019)

JAK Kinases in Health and Disease: An Update
por: Laurence, Arian, et al.
Publicado: (2012)

What is the point of pseudokinases?
por: Raju, Saravanan, et al.
Publicado: (2015)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Editorial: JAK inhibition in autoimmune and inflammatory diseases
por: Telliez, Jean-Baptiste, et al.
Publicado: (2022)

A novel germline hyperactivating JAK2 mutation L604F
por: Dvořáček, Lukáš, et al.
Publicado: (2023)

Ab Initio Modeling and Experimental Assessment of Janus Kinase 2 (JAK2) Kinase-Pseudokinase Complex Structure
por: Wan, Xiaobo, et al.
Publicado: (2013)

Pseudokinase is active after all
por: LeBrasseur, Nicole
Publicado: (2008)

Tribbles Pseudokinases in Colorectal Cancer
por: Ferreira, Bibiana I., et al.
Publicado: (2021)

Pseudokinases, Tribbles Proteins and Cancer
por: Velasco, Guillermo, et al.
Publicado: (2023)

IRF2BP2 Mutation Is Associated with Increased STAT1 and STAT5 Activation in Two Family Members with Inflammatory Conditions and Lymphopenia
por: Palmroth, Maaria, et al.
Publicado: (2021)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

JAK2 V617F Constitutive Activation Requires JH2 Residue F595: A Pseudokinase Domain Target for Specific Inhibitors
por: Dusa, Alexandra, et al.
Publicado: (2010)

SCYL pseudokinases in neuronal function and survival
por: Pelletier, Stephane
Publicado: (2016)

Pharmacological Targeting of the Pseudokinase Her3
por: Xie, Ting, et al.
Publicado: (2014)

Analysis of Jak2 Catalytic Function by Peptide Microarrays: The Role of the JH2 Domain and V617F Mutation
por: Sanz, Arturo, et al.
Publicado: (2011)

The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling
por: Tactacan, Carole M., et al.
Publicado: (2015)

ATP and MO25α Regulate the Conformational State of the STRADα Pseudokinase and Activation of the LKB1 Tumour Suppressor
por: Zeqiraj, Elton, et al.
Publicado: (2009)

Structure of Fam20A reveals a pseudokinase featuring a unique disulfide pattern and inverted ATP-binding
por: Cui, Jixin, et al.
Publicado: (2017)

SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
por: Yan, Bingyu, et al.
Publicado: (2021)

Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B
por: Cipriano, Rocky, et al.
Publicado: (2013)

Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS
por: Wang, Dan, et al.
Publicado: (2019)

Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR Inhibitors
por: Jacome Sanz, Dafne, et al.
Publicado: (2021)

Crystal structure of DRIK1, a stress-responsive receptor-like pseudokinase, reveals the molecular basis for the absence of ATP binding
por: Aquino, Bruno, et al.
Publicado: (2020)

Pseudokinases-remnants of evolution or key allosteric regulators?
por: Zeqiraj, Elton, et al.
Publicado: (2010)

The real role of pseudokinase: linking diabetes to cancers
por: Li, Ke, et al.
Publicado: (2016)

Tribbles Pseudokinase 3 Regulation and Contribution to Cancer
por: Stefanovska, Bojana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3f3q26belibv2trd05rg70jst6